Drugs / HD-Fluzone
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT04077424 Comparator | Oct 2019 → Feb 2020 | — | Vanderbilt University Medical Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HD-Fluzone | “FDA approved high dose inactivated influenza vaccine (HD-Fluzone)” NCT04077424 ↗ |
| Known as | Fluzone-High Dose Quadrivalent | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04077424 ↗ |
| Modality | Vaccine | “FDA approved high dose inactivated influenza vaccine (HD-Fluzone)” NCT04077424 ↗ |